GT
AMPH icon

Glenmede Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

Glenmede Trust’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24,743
Closed -$919K – 1376
2024
Q4 		$919K Sell
24,743
-13,141
-35% -$601K ﹤0.01% 748
2024
Q3 		$1.84M Buy
37,884
+22,439
+145% +$985K 0.01% 583
2024
Q2 		$618K Sell
15,445
-1,591
-9% -$65.9K ﹤0.01% 825
2024
Q1 		$748K Sell
17,036
-1,080
-6% -$55.8K ﹤0.01% 791
2023
Q4 		$1.12M Buy
18,116
+7,672
+73% +$403K 0.01% 661
2023
Q3 		$480K Sell
10,444
-27
-0.3% -$1.47K ﹤0.01% 854
2023
Q2 		$393K Hold
10,471
– – ﹤0.01% 901
2023
Q1 		$393K Sell
10,471
-29
-0.3% -$951 ﹤0.01% 906
2022
Q4 		$294K Sell
10,500
-365
-3% -$10.6K ﹤0.01% 989
2022
Q3 		$305K Buy
10,865
+318
+3% +$10.4K ﹤0.01% 954
2022
Q2 		$366K Buy
+10,547
New +$376K ﹤0.01% 948
2020
Q4 		– Sell
-104
Closed -$1K – 1241
2020
Q3 		$1K Sell
104
-98
-49% -$1.97K ﹤0.01% 2317
2020
Q2 		$4K Sell
202
-474
-70% -$8.68K ﹤0.01% 2108
2020
Q1 		$13K Hold
676
– – ﹤0.01% 2290
2019
Q4 		$13K Buy
676
+131
+24% +$2.51K ﹤0.01% 2290
2019
Q3 		$10K Sell
545
-10
-2% -$208 ﹤0.01% 2335
2019
Q2 		$11K Sell
555
-42
-7% -$878 ﹤0.01% 2324
2019
Q1 		$12K Hold
597
– – ﹤0.01% 2285
2018
Q4 		$11K Buy
+597
New +$11.8K ﹤0.01% 2223

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's AMPH Position: Q1 2025 in Review

Glenmede Trust sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 24,743 shares — an estimated $919K sold.

Glenmede Trust first reported a position in AMPH in Q4 2018 and held it in 19 quarters. The position peaked at $1.84M in Q3 2024. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Glenmede Trust reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Glenmede Trust sold 24,743 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $919K.
  • Glenmede Trust first reported a position in Amphastar Pharmaceuticals in Q4 2018 and held it in 19 quarters.
  • Glenmede Trust's Amphastar Pharmaceuticals position peaked at $1.84M in Q3 2024.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.